Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2026Advanced Pharmaceutical BulletinOpen Access

Gut microbiome influences the efficacy of neuropsychiatric drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAnjal Mohamed AgeelKSKannan SubbaramSASheeza Ali

Discussion

Loading...

Member takes

Overview

Randomized trial examines gut microbiome's impact on neuropsychiatric drug effectiveness, suggesting significant implications for treatment strategies.

Key Points

  • This research explores how the gut microbiome affects the efficacy of neuropsychiatric medications.
  • Assessed the composition of gut microbiome in relation to neuropsychiatric drug response.
  • Investigated dysbiosis as a factor affecting drug efficacy.
  • Evaluated the metabolic functions of gut bacteria related to drug metabolism.
  • Dysbiosis correlated with reduced efficacy of certain neuropsychiatric drugs.
  • Alterations in specific bacterial populations negatively impacted drug metabolism and effectiveness.
  • A significant relationship between gut microbiome composition and treatment outcomes was observed.

Cite This Study

Ageel et al. (2026) studied this question.

synapsesocial.com/papers/6a3632d2db0793dc1a5395bdhttps://doi.org/10.34172/apb.47093
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The gut–brain axis in pharmacology: microbiome-driven modulation of CNS drugs and neuropsychiatric outcomes2026
  2. 2Microbial dysbiosis and associated human diseases2024 · 6 citations
  3. 3Drugs Versus Microbiota: How Pharmacotherapy Affects Gut and Probiotic Bacteria2025 · 14 citations
  4. 4DYSBIOSIS AND HUMAN HEALTH, DRUG–MICROBIOME INTERACTIONS: AN EMERGING MICROBIOME THERAPEUTICS2026
  5. 5The Microbiota-Gut-Brain Axis: A New Frontier in Precision Neuropsychopharmacology2026